Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024

BUY
$0.42 - $0.72 $1,226 - $2,102
2,920 Added 3.08%
97,616 $61,000
Q3 2023

Oct 23, 2023

SELL
$0.6 - $1.53 $208 - $530
-347 Reduced 0.37%
94,696 $57,000
Q2 2023

Aug 10, 2023

BUY
$1.05 - $1.63 $44,854 - $69,631
42,719 Added 81.64%
95,043 $107,000
Q1 2023

May 11, 2023

SELL
$1.2 - $2.73 $1,350 - $3,071
-1,125 Reduced 2.1%
52,324 $70,000
Q4 2022

Feb 07, 2023

SELL
$1.71 - $3.61 $10,660 - $22,504
-6,234 Reduced 10.45%
53,449 $99,000
Q3 2022

Nov 14, 2022

BUY
$1.9 - $8.63 $58,708 - $266,658
30,899 Added 107.35%
59,683 $146,000
Q2 2022

Jul 19, 2022

SELL
$2.13 - $9.01 $22,443 - $94,938
-10,537 Reduced 26.8%
28,784 $70,000
Q1 2022

May 04, 2022

BUY
$6.28 - $15.59 $32,517 - $80,725
5,178 Added 15.17%
39,321 $313,000
Q4 2021

Jan 31, 2022

SELL
$14.7 - $28.67 $327,236 - $638,222
-22,261 Reduced 39.47%
34,143 $521,000
Q3 2021

Oct 29, 2021

BUY
$24.31 - $33.6 $57,639 - $79,665
2,371 Added 4.39%
56,404 $1.6 Million
Q2 2021

Aug 11, 2021

SELL
$26.09 - $40.4 $2.22 Million - $3.44 Million
-85,260 Reduced 61.21%
54,033 $1.82 Million
Q1 2021

May 04, 2021

BUY
$33.06 - $56.93 $947,499 - $1.63 Million
28,660 Added 25.91%
139,293 $5.32 Million
Q4 2020

Feb 11, 2021

BUY
$39.09 - $57.4 $1.19 Million - $1.74 Million
30,379 Added 37.85%
110,633 $4.63 Million
Q3 2020

Nov 05, 2020

SELL
$28.43 - $44.67 $449,648 - $706,500
-15,816 Reduced 16.46%
80,254 $3.48 Million
Q2 2020

Aug 12, 2020

BUY
$11.71 - $30.29 $299,811 - $775,514
25,603 Added 36.33%
96,070 $2.91 Million
Q1 2020

May 11, 2020

BUY
$7.64 - $27.5 $43,784 - $157,602
5,731 Added 8.85%
70,467 $963,000
Q4 2019

Feb 05, 2020

BUY
$15.02 - $20.57 $317,703 - $435,096
21,152 Added 48.53%
64,736 $1.04 Million
Q3 2019

Oct 30, 2019

BUY
$18.85 - $27.5 $205,219 - $299,392
10,887 Added 33.3%
43,584 $839,000
Q2 2019

Jul 19, 2019

BUY
$17.37 - $26.27 $46,968 - $71,034
2,704 Added 9.02%
32,697 $768,000
Q1 2019

May 13, 2019

BUY
$10.65 - $25.75 $66,051 - $159,701
6,202 Added 26.07%
29,993 $702,000
Q4 2018

Feb 11, 2019

BUY
$9.26 - $16.38 $31,511 - $55,741
3,403 Added 16.69%
23,791 $263,000
Q3 2018

Nov 06, 2018

BUY
$7.54 - $18.31 $153,725 - $373,304
20,388 New
20,388 $341,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.